Cytokinetics financials
WebMar 24, 2024 · CYTOKINETICS, INCORPORATED : Forcasts, revenue, earnings, analysts expectations, ratios for CYTOKINETICS, INCORPORATED Stock CYTK US23282W6057 WebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled ...
Cytokinetics financials
Did you know?
WebCytokinetics Stock Is Surging. Heart-Drug Results Are Exciting Investors. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-4.25 Market Cap $3.46 B Shares Outstanding 95.16 … WebApr 10, 2024 · Forward-looking statements are not guarantees of future performance, and Cytokinetics' actual results of operations, financial condition and liquidity, and the development of the industry in which ...
WebJun 27, 2024 · Financials CYTK has a market cap of $4.05bn and a cash balance of $686mn. Research and development expenses for the first quarter 2024 were $45.9 million, while general and administrative... WebDescription. Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle …
WebFeb 6, 2014 · Financial Guidance 2014. Cytokinetics also announced its financial guidance for 2014. The company anticipates cash revenue will be in the range of $19 to $21 million, cash R&D expenses will be in ... WebCYTK Finanicals Stock Screener Earnings Calendar Sectors Nasdaq CYTK U.S.: Nasdaq Cytokinetics Inc. Watch list Create CYTK Alert After Hours Last Updated: Mar 8, 2024 …
WebCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential …
WebApr 11, 2024 · Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 33.36 -0.27 (-0.80%) At close: 04:00PM EDT 33.36 0.00 (0.00%) After hours: 04:11PM EDT Time... darin toohey university of colorado boulderWebCYTK Cytokinetics Inc. Annual Income Statement - WSJ Subscribe Sign In Cytokinetics Inc. CYTK (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT … birthstones for november 11WebAug 5, 2024 · SOUTH SAN FRANCISCO, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported financial results for the second quarter of 2024. ... Financials. Revenues for the ... birthstones for all the monthsWebNov 4, 2024 · Inside Cytokinetics Inc's 10-Q Quarterly Report: Financial - Expense Highlight. Each of these adjustments is accounted for on a prospective basis in our liability calculation and resulted in a decline in our imputed interest rate and noncash interest expenses from 10% and $4.4 million in the second quarter of 2024 to 7.5% and $3.4 … birthstones for juneWebApr 10, 2024 · Forward-looking statements are not guarantees of future performance, and Cytokinetics' actual results of operations, financial condition and liquidity, and the … birthstones for november 22WebCYTK Cytokinetics Inc. Annual Income Statement - WSJ Subscribe Sign In Cytokinetics Inc. CYTK (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT 03/28/23 $34.98 … birthstones meanings and flowersWebApr 5, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media. Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. birthstones necklace for mother